Antiarrhythmic drug dosing methods, medical devices, and systems
The disclosure relates to a method which includes i) prompting input of: a creatinine clearance (CrCl) of a subject; whether the subject is being initiated or escalated on sotalol hydrochloride; an amount of an oral target dosage of sotalol hydrochloride for the subject; and optionally a projected start time for sotalol hydrochloride infusion; and ii) executing computer executable instructions to derive from a set of rules a sotalol hydrochloride dosing protocol for the subject based on the inputs. The disclosure also relates to systems and medical devices configured to perform one or more steps of the method, as well as a non-transitory computer-readable storage medium comprising computer-executable instructions or software stored thereon capable of performing one or more steps of the method.
1. A treatment management application configured to perform a set of operations comprising:
(i) reading, prompting input of and/or accepting the following as inputs:
a projected start time for a sotalol hydrochloride 1 hour infusion;
a creatinine clearance (CrCl) or creatinine level of a subject;
whether the subject is being initiated or escalated on the sotalol hydrochloride; and
an amount of an oral target dosage of sotalol hydrochloride for the subject; and
(ii) executing computer executable instructions to derive from a set of rules a sotalol hydrochloride IV and oral dosing protocol for the subject based on the inputs, the dosing protocol comprising:
one or more amount of the sotalol hydrochloride for infusion as a loading dose;
a time for a first oral dose of sotalol hydrochloride; and
optionally a time for a second oral dose of sotalol hydrochloride; and
(iii) outputting the sotalol hydrochloride IV and oral dosing protocol.
2. The treatment management application of claim 1 , wherein the set of operations further comprises reading, prompting input of and/or accepting as an input an actual start time for the sotalol hydrochloride infusion and outputting a revised dosing protocol with confirmed or updated times for the first oral sotalol hydrochloride dose and optionally the second oral sotalol hydrochloride dose.
3. The treatment management application of claim 1 , wherein:
for the subject who has a CrCl of >90 mL/min and is being initiated on an 80 mg target oral sotalol hydrochloride dose, the dosing protocol comprises:
60 mg as the amount for the infusion of sotalol hydrochloride as the loading dose;
a time of at least 4 hours after completion of the loading dose as the time for the first oral dose; and
a time of 12 hours after the first oral dose as the time for the second oral dose.
4. The treatment management application of claim 1 , wherein:
for the subject who has a CrCl of 60-90 mL/min and is being initiated on an 80 mg target oral sotalol hydrochloride dose, the dosing protocol comprises:
82.5 mg as the amount for the infusion as the loading dose;
a time of at least 4 hours after completion of the loading dose as the time for the first oral dose; and
a time of 12 hours after the first oral dose as the time for the second oral dose.
5. The treatment management application of claim 1 , wherein:
for the subject who has a CrCl of 30-60 mL/min and is being initiated on an 80 mg target oral sotalol hydrochloride dose, the dosing protocol comprises:
75 mg as the amount for the infusion as the loading dose;
a time of at least 6 hours after completion of the loading dose as the time for the first oral dose; and
a time of 24 hours after the first oral dose as the time for the second oral dose.
6. The treatment management application of claim 1 , wherein:
for the subject who has a CrCl of 10-30 mL/min and is being initiated on an 80 mg target oral sotalol hydrochloride dose, the dosing protocol comprises:
75 mg as the amount for the infusion as the loading dose;
a time of at least 12 hours after completion of the loading dose as the time for the first oral dose; and
a time of 48 hours after the first oral dose as the time for the second oral dose.
7. The treatment management application of claim 1 , wherein:
for the subject who has a CrCl of >90 mL/min and is being initiated on an 120 mg target oral sotalol hydrochloride dose, the dosing protocol comprises:
75 mg as the amount for the infusion as the loading dose;
a time of at least 4 hours after completion of the loading dose as the time for the first oral dose; and
a time of 12 hours after the first oral dose as the time for the second oral dose.
8. The treatment management application of claim 1 , wherein:
for the subject who has a CrCl of 60-90 mL/min and is being initiated on an 120 mg target oral sotalol hydrochloride dose, the dosing protocol comprises:
82.5 mg as the amount for the infusion as the loading dose;
a time of at least 4 hours after completion of the loading dose as the time for the first oral dose; and
a time of 12 hours after the first oral dose as the time for the second oral dose.
9. The treatment management application of claim 1 , wherein:
for the subject who has a CrCl of 30-60 mL/min and is being initiated on an 120 mg target oral sotalol hydrochloride dose, the dosing protocol comprises:
82.5 mg as the amount for the infusion as the loading dose;
a time of at least 6 hours after completion of the loading dose as the time for the first oral dose; and
a time of 24 hours after the first oral dose as the time for the second oral dose.
10. The treatment management application of claim 1 , wherein:
for the subject who has a CrCl of 10-30 mL/min and is being initiated on an 120 mg target oral sotalol hydrochloride dose, the dosing protocol comprises:
82.5 mg as the amount for the infusion as the loading dose;
a time of at least 12 hours after completion of the loading dose as the time for the first oral dose; and
a time of 48 hours after the first oral dose as the time for the second oral dose.
11. The treatment management application of claim 1 , wherein:
for the subject who has a CrCl of >90 mL/min and is being escalated from an oral dose of 80 mg to a target oral sotalol hydrochloride dose of 120 mg, the dosing protocol comprises:
90 mg as the amount for the infusion as the loading dose;
a time of at least 4 hours after completion of the loading dose as the time for the first oral dose; and
a time of 12 hours after the first oral dose as the time for the second oral dose.
12. The treatment management application of claim 1 , wherein:
for the subject who has a CrCl of 60-90 mL/min and is being escalated from an oral dose of 80 mg to a target oral sotalol hydrochloride dose of 120 mg, the dosing protocol comprises:
125 mg as the amount for the infusion as the loading dose;
a time of at least 4 hours after completion of the loading dose as the time for the first oral dose; and
a time of 12 hours after the first oral dose as the time for the second oral dose.
13. The treatment management application of claim 1 , wherein:
for the subject who has a CrCl of 30-60 mL/min and is being escalated from an oral dose of 80 mg to a target oral sotalol hydrochloride dose of 120 mg, the dosing protocol comprises:
2 112.5 mg as the amount for the infusion as the loading dose;
a time of at least 6 hours after completion of the loading dose as the time for the first oral dose; and
a time of 24 hours after the first oral dose as the time for the second oral dose.
14. The treatment management application of claim 1 , wherein:
for the subject who has a CrCl of 10-30 mL/min and is being escalated from an oral dose of 80 mg to a target oral sotalol hydrochloride dose of 120 mg, the dosing protocol comprises:
112.5 mg as the amount for the infusion as the loading dose;
a time of at least 12 hours after completion of the loading dose as the time for the first oral dose; and
a time of 48 hours after the first oral dose as the time for the second oral dose.
15. The treatment management application of claim 1 , wherein:
for the subject who has a CrCl of >90 mL/min and is being escalated from an oral dose of 120 mg to a target oral sotalol hydrochloride dose of 160 mg, the dosing protocol comprises:
90 mg as the amount for the infusion as the loading dose;
a time of at least 4 hours after completion of the loading dose as the time for the first oral dose; and
a time of 12 hours after the first oral dose as the time for the second oral dose.
16. The treatment management application of claim 1 , wherein:
for the subject who has a CrCl of 60-90 mL/min and is being escalated from an oral dose of 120 mg to a target oral sotalol hydrochloride dose of 160 mg, the dosing protocol comprises:
105 mg as the amount for the infusion as the loading dose;
a time of at least 4 hours after completion of the loading dose as the time for the first oral dose; and
a time of 12 hours after the first oral dose as the time for the second oral dose.
17. The treatment management application of claim 1 , wherein:
for the subject who has a CrCl of 30-60 mL/min and is being escalated from an oral dose of 120 mg to a target oral sotalol hydrochloride dose of 160 mg, the dosing protocol comprises:
105 mg as the amount for the infusion as the loading dose;
a time of at least 6 hours after completion of the loading dose as the time for the first oral dose; and
a time of 24 hours after the first oral dose as the time for the second oral dose.
18. The treatment management application of claim 1 , wherein:
for the subject who has a CrCl of 10-30 mL/min and is being escalated from an oral dose of 120 mg to a target oral sotalol hydrochloride dose of 160 mg, the dosing protocol comprises:
105 mg as the amount for the infusion as the loading dose;
a time of at least 12 hours after completion of the loading dose as the time for the first oral dose; and
a time of 48 hours after the first oral dose as the time for the second oral dose.
19. A medical device comprising:
an electronic device, optionally a handheld electronic device;
software stored on or accessible to the electronic device and operably configured to:
(i) read, prompt input of and/or accept as inputs: a creatinine clearance (CrCl) of a subject; whether the subject is being initiated or escalated on sotalol hydrochloride; an amount of an oral target dosage of sotalol hydrochloride for the subject; and a projected or actual start time for sotalol hydrochloride infusion; and
(ii) execute computer executable instructions to derive from a set of rules an IV and oral sotalol hydrochloride dosing protocol for the subject based on one or more of or all of the inputs, the dosing protocol comprising at least one or more amount of the sotalol hydrochloride for infusion as a loading dose and a time for a first oral dose of sotalol hydrochloride based on the projected or actual start time; and
(iii) output the sotalol hydrochloride dosing protocol; and
a display capable of displaying the output of the dosing protocol to a user.
20. A method of treating a subject comprising:
administering sotalol hydrochloride to a subject based on outputs from a treatment management application configured to perform a set of operations comprising:
(i) reading, prompting input of and/or accepting the following as inputs:
a projected start time for a sotalol hydrochloride 1 hour infusion;
a creatinine clearance (CrCl) or creatinine level of a subject;
whether the subject is being initiated or escalated on the sotalol hydrochloride; and
an amount of an oral target dosage of sotalol hydrochloride for the subject; and
(ii) executing computer executable instructions to derive from a set of rules an IV and oral sotalol hydrochloride dosing protocol for the subject based on the inputs, the dosing protocol comprising:
one or more amount of the sotalol hydrochloride for infusion as a loading dose;
a time for a first oral dose of sotalol hydrochloride; and
optionally a time for a second oral dose of sotalol hydrochloride; and
(iii) outputting the sotalol hydrochloride dosing protocol; and
optionally administering the sotalol hydrochloride in a manner for providing for maintenance of normal sinus rhythm in patients with symptomatic atrial fibrillation or atrial flutter and/or who are currently in sinus rhythm.